Iron Replacement as A Therapeutic Approach For Renal Phosphate Wasting With Associated Iron Deficiency
ABSTRACT: Objective: Fibroblast growth factor 23 (FGF23) dysregulation is implicated in the pathogenesis of hypophosphatemic disorders, including X-linked hypophosphatemic rickets, autosomal dominant hypophosphatemic rickets (ADHR), autosomal recessive hypophosphatemic rickets, and tumor-induced ost...
Main Authors: | Aditi Kumar, MD, Robert A. Wermers, MD, Peter J. Tebben, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520301723 |
Similar Items
-
Iron Chelation Resulting in Renal Phosphate Wasting
by: Lynda Cheddani, et al.
Published: (2018-01-01) -
Iron Supplements for Infants at Risk for Iron Deficiency
by: Brianna C. MacQueen MD, et al.
Published: (2017-04-01) -
Iron deficiency in therapeutic practice. The specifics of iron deficiency and iron deficiency anemia prevention
by: G. N. Gorokhovskaya, et al.
Published: (2014-12-01) -
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
by: Fabiana Busti, et al.
Published: (2018-09-01) -
Iron and Phosphate Deficiency Regulators Concertedly Control Coumarin Profiles in Arabidopsis thaliana Roots During Iron, Phosphate, and Combined Deficiencies
by: Ranju Chutia, et al.
Published: (2019-02-01)